|
Ani Pharmaceuticals Inc (NASDAQ: ANIP) |
|
Ani Pharmaceuticals Inc
ANIP's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Ani Pharmaceuticals Inc growth rates, revenue grew
by 44.75 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 351
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Ani Pharmaceuticals Inc faced net loss in contrast to the net income a year ago in IV. Quarter 2024
• More on ANIP's Growth
|
|
Ani Pharmaceuticals Inc realized a net loss in trailing twelve months.
Ani Pharmaceuticals Inc realized cash reduction of $ -3.93 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on ANIP's Valuation
|
|
|
|
|
Ani Pharmaceuticals Inc realized net loss in trailing twelve months.
Ani Pharmaceuticals Inc realized cash outflow of $ -3.93per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Ani Pharmaceuticals Inc Price to Book Ratio is at 3.35 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01
• More on ANIP's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com